Sorafenib and thrombocytopenia Patient Reports February 10, 2012



Sorafenib Side Effects Report #5844964-8
Sorafenib side effect was reported by a Pharmacist from UNITED STATES on Aug 13, 2008. Male patient, 69 years of age, weighting 127.4 lb, was diagnosed with renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: myelodysplastic syndrome, neutropenic sepsis, thrombocytopenia. Sorafenib dosage: 400 MG BID PO. Patient was hospitalized. Patient recovered.

Sorafenib Side Effects Report #5848548-7
Sorafenib side effect was reported by a Pharmacist from UNITED STATES on Aug 15, 2008. Male patient, 69 years of age, weighting 127.4 lb, was diagnosed with renal cell carcinoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: myelodysplastic syndrome, neutropenic sepsis, thrombocytopenia. Sorafenib dosage: 400 MG BID PO. Patient was hospitalized. Patient died.

Sorafenib Side Effects Report #5793741-5
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on June 13, 2008. Male patient was diagnosed with prostate cancer metastatic and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: catheter thrombosis, exfoliative rash, fatigue, hyperkalaemia, infection What is  infection, nausea What is  nausea, pharyngolaryngeal pain, thrombocytopenia. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. Patient recovered.

Sorafenib Side Effects Report #5795841-2
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on June 13, 2008. Male patient was diagnosed with prostate cancer metastatic and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: catheter thrombosis, exfoliative rash, fatigue, hyperkalaemia, infection What is  infection, nausea What is  nausea, oropharyngeal pain, thrombocytopenia. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. Patient recovered.


Sorafenib Side Effects Report #6091472-8
Sorafenib side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 24, 2009. Male patient was diagnosed with prostate cancer metastatic and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: catheter thrombosis, exfoliative rash, fatigue, hyperkalaemia, infection What is  infection, nausea What is  nausea, oropharyngeal pain, thrombocytopenia. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. Patient recovered.

Sorafenib Side Effects Report #5514007-4
Sorafenib side effect was reported by a Health Professional from UNITED STATES on Nov 05, 2007. Female patient, 59 years of age, weighting 194.0 lb, was diagnosed with ovarian cancer, depression What is  depression, diabetes mellitus, osteoporosis What is  osteoporosis and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: anaemia, asthenia, electrolyte imbalance, failure to thrive, hypotension, pancytopenia, thrombocytopenia. Sorafenib dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOL, EFFEXOR, GLUCOPHAGE, ACTONEL. Patient was hospitalized. Patient recovered.

Sorafenib Side Effects Report #6029520-3
Sorafenib side effect was reported by a Physician from UNITED STATES on Dec 04, 2007. Female patient, 59 years of age, weighting 194.0 lb, was diagnosed with ovarian cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: anaemia, asthenia, electrolyte imbalance, failure to thrive, hypotension, pancytopenia, thrombocytopenia. Sorafenib dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOL. Patient recovered.

Sorafenib Side Effects Report #5649447-6
Sorafenib side effect was reported by a Physician from BRAZIL on Sept 06, 2007. Female patient, 81 years of age, weighting 121.3 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: anaemia, anorexia, constipation What is  constipation, dehydration, neutropenia, pain in extremity, subcutaneous nodule, thrombocytopenia, vomiting. Sorafenib dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.

Sorafenib Side Effects Report #5399367-X
Sorafenib side effect was reported by a Physician from GERMANY on July 20, 2007. Male patient, 76 years of age, weighting 174.2 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dermatitis exfoliative, thrombocytopenia. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with CISPLATIN, GEMCITABINE, RAMIPRIL, NORVASC, GLUCOPHAGE, DURAGESIC, NOVALGIN. Patient was hospitalized. Patient recovered.


Sorafenib Side Effects Report #5490680-4
Sorafenib side effect was reported by a Physician from GERMANY on Oct 17, 2007. Male patient, 76 years of age, weighting 174.2 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dermatitis exfoliative, thrombocytopenia. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with CISPLATIN, GEMCITABINE, RAMIPRIL, NORVASC, GLUCOPHAGE, DURAGESIC, NOVALGIN. Patient was hospitalized. Patient recovered.

Sorafenib Side Effects Report #5480203-8
Sorafenib side effect was reported by a Physician from GERMANY on Oct 04, 2007. Male patient, 68 years of age, weighting 143.3 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: anorexia, pharyngitis, thrombocytopenia, weight decreased. Sorafenib dosage: UNIT DOSE: 400 MG. During the same period patient was treated with GEMCITABINE, CISPLATIN. Patient was hospitalized. Patient recovered.

Sorafenib Side Effects Report #5490682-8
Sorafenib side effect was reported by a Physician from GERMANY on Oct 17, 2007. Male patient, 68 years of age, weighting 143.3 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: anorexia, pharyngitis, thrombocytopenia, weight decreased. Sorafenib dosage: UNIT DOSE: 400 MG. During the same period patient was treated with GEMCITABINE, CISPLATIN. Patient was hospitalized. Patient recovered.

Sorafenib Side Effects Report #5649426-9
Sorafenib side effect was reported by a Physician from ITALY on Feb 20, 2008. Male patient, 67 years of age, weighting 158.7 lb, was diagnosed with non-small cell lung cancer, ill-defined disorder, hypertension and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: hypercreatininaemia, neutropenia, thrombocytopenia. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, PLAVIX, ADALAT. Patient was hospitalized. Patient died on 03/23/2007.

Sorafenib Side Effects Report #5717671-X
Sorafenib side effect was reported by a Physician from ITALY on Apr 21, 2008. Male patient, 67 years of age, weighting 158.7 lb, was diagnosed with non-small cell lung cancer, ill-defined disorder, hypertension and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: hypercreatininaemia, neutropenia, thrombocytopenia. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, PLAVIX, ADALAT. Patient was hospitalized. Patient died on 03/23/2007.


Sorafenib Side Effects Report #5888505-8
Sorafenib side effect was reported by a Physician from ITALY on Apr 18, 2008. Male patient, 67 years of age, weighting 158.7 lb, was diagnosed with non-small cell lung cancer, ill-defined disorder, hypertension and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: hypercreatininaemia, neutropenia, thrombocytopenia. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, PLAVIX, ADALAT. Patient was hospitalized. Patient died on 03/23/2007.

Sorafenib Side Effects Report #5451157-5
Sorafenib side effect was reported by a Physician from NETHERLANDS on Sept 04, 2007. Male patient, 65 years of age, was diagnosed with non-small cell lung cancer, intercostal neuralgia, prophylaxis, dyspnoea and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, leukopenia, thrombocytopenia. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with CISPLATIN, GEMCITABINE, AMITRIPTYLINE, LYRICA, OMEPRAZOLE, ATROVENT. Patient was hospitalized. Patient died on 08/26/2007.

Sorafenib Side Effects Report #5044944-9
Sorafenib side effect was reported by a Physician from UNITED STATES on June 21, 2006. Male patient, 64 years of age, weighting 157.0 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: anaemia, carotid artery stenosis, cerebral infarction, cerebral ischaemia, deep vein thrombosis What is  deep vein thrombosis, thrombocytopenia. Sorafenib dosage: 400 MG, BID, ORAL. Patient was hospitalized. Patient recovered.

Sorafenib Side Effects Report #5649436-1
Sorafenib side effect was reported by a Physician from GERMANY on Feb 20, 2008. Male patient, 56 years of age, weighting 99.21 lb, was diagnosed with non-small cell lung cancer, medical diet and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: cardiac failure congestive, dehydration, lung neoplasm malignant, renal failure, respiratory failure, sepsis What is  sepsis, sinus tachycardia, thrombocytopenia. Sorafenib dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 200 MG. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, FISH OIL, ESTER C. Patient was hospitalized. Patient died on 08/15/2006.

Sorafenib Side Effects Report #5669808-9
Sorafenib side effect was reported by a Physician from GERMANY on Mar 11, 2008. Male patient, 56 years of age, weighting 99.21 lb, was diagnosed with non-small cell lung cancer, medical diet and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: cardiac failure congestive, dehydration, lung neoplasm malignant, renal failure, respiratory failure, sepsis What is  sepsis, sinus tachycardia, thrombocytopenia. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, FISH OIL, ESTER C. Patient was hospitalized. Patient died on 08/15/2006.


Sorafenib Side Effects Report #5728310-6
Sorafenib side effect was reported by a Physician from UNITED STATES on Apr 18, 2008. Male patient, 56 years of age, weighting 99.21 lb, was diagnosed with non-small cell lung cancer, medical diet and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: cardiac failure congestive, dehydration, lung neoplasm malignant, renal failure, respiratory failure, sepsis What is  sepsis, sinus tachycardia, thrombocytopenia. Sorafenib dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 200 MG. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, FISH OIL, ESTER C. Patient was hospitalized. Patient died on 08/15/2006.

Sorafenib Side Effects Report #6085258-8
Sorafenib side effect was reported by a Physician from GREECE on Feb 16, 2009. Female patient, 53 years of age, weighting 105.8 lb, was diagnosed with non-small cell lung cancer, hyperthyroidism, hyperlipidaemia, prophylaxis of nausea and vomiting, anaemia and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: catheter related infection, epistaxis, pneumonia What is  pneumonia, pyrexia, thrombocytopenia. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG. During the same period patient was treated with CISPLATIN, GEMCITABINE, THYROHORMONE, SIMVASTATIN, ZOFRON, EPREX, ATORVASTATIN. Patient was hospitalized. Patient recovered.

Sorafenib Side Effects Report #5649434-8
Sorafenib side effect was reported by a Physician from UNITED KINGDOM on Feb 20, 2008. Male patient, 41 years of age, weighting 222.7 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: thrombocytopenia. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, DEXAMETHASONE, KEVATRIL, ECURAL, POLYHEXANID. Patient was hospitalized. Patient recovered.

Sorafenib Side Effects Report #5873919-2
Sorafenib side effect was reported by a Physician from UNITED KINGDOM on Apr 17, 2008. Male patient, 41 years of age, weighting 222.7 lb, was diagnosed with non-small cell lung cancer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: thrombocytopenia. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, DEXAMETHASONE, KEVATRIL, ECURAL, POLYHEXANID. Patient was hospitalized. Patient recovered.

Sorafenib Side Effects Report #5159551-7
Sorafenib side effect was reported by a Physician from UNITED STATES on Oct 18, 2006. Male patient, 50 years of age, was diagnosed with metastatic malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: anaemia macrocytic, bone pain, cardio-respiratory arrest, leukocytosis, marrow hyperplasia, neutrophilia, pyrexia, thrombocytopenia, vomiting. Sorafenib dosage: unknown. During the same period patient was treated with ALEVE. Patient was hospitalized. Patient recovered.


Sorafenib Side Effects Report #5743776-3
Sorafenib side effect was reported by a Physician from GERMANY on May 16, 2008. Female patient, 49 years of age, weighting 143.3 lb, was diagnosed with metastatic malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: coagulopathy, subdural haemorrhage, thrombocytopenia. Sorafenib dosage: unknown. During the same period patient was treated with VOMEX A, NEXIUM, OCTAPLEX, DISOPRIVAN, MANNITOL. Patient was hospitalized. Patient died on 05/11/2008.

Sorafenib Side Effects Report #5744174-9
Sorafenib side effect was reported by a Physician from GERMANY on May 16, 2008. Female patient, 49 years of age, weighting 143.3 lb, was diagnosed with metastatic malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: coagulopathy, subdural haemorrhage, thrombocytopenia. Sorafenib dosage: unknown. During the same period patient was treated with VOMEX A, NEXIUM, OCTAPLEX. Patient was hospitalized. Patient died on 05/11/2008.

Sorafenib Side Effects Report #5775277-0
Sorafenib side effect was reported by a Physician from GERMANY on June 10, 2008. Female patient, 49 years of age, weighting 143.3 lb, was diagnosed with metastatic malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: blood urine present, brain oedema, coagulopathy, gingival bleeding, subdural haemorrhage, thrombocytopenia. Sorafenib dosage: unknown. During the same period patient was treated with METOCLOPRAMIDE, VOMEX A, NEXIUM, OCTAPLEX. Patient was hospitalized. Patient died on 05/11/2008.

Sorafenib Side Effects Report #5159533-5
Sorafenib side effect was reported by a Physician from UNITED STATES on May 22, 2006. Female patient, 44 years of age, weighting 242.5 lb, was diagnosed with metastatic malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: blood fibrinogen increased, disease progression, hepatic failure, hypotension, respiratory distress, sinus tachycardia, thrombocytopenia, white blood cell count increased. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with WELLBUTRIN, EFFEXOR, KLONOPIN, TYLENOL, REGULAR INSULIN, AMBIEN, STATIN. Patient was hospitalized. Patient died on 05/21/2006.

Sorafenib Side Effects Report #6130909-2
Sorafenib side effect was reported by a Physician from GERMANY on Mar 19, 2009. Male patient, 44 years of age, weighting 202.8 lb, was diagnosed with metastatic malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: dehydration, hyperventilation, tachycardia, thrombocytopenia. Sorafenib dosage: unknown. Patient was hospitalized. Patient recovered.


Sorafenib Side Effects Report #5756603-5
Sorafenib side effect was reported by a Physician from GERMANY on May 28, 2008. Female patient, 76 years of age, weighting 174.2 lb, was diagnosed with malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: asthenia, fatigue, lethargy, malaise, thrombocytopenia. Sorafenib dosage: unknown. Patient was hospitalized. Patient recovered.

Sorafenib Side Effects Report #5789187-6
Sorafenib side effect was reported by a Physician from GERMANY on June 23, 2008. Male patient, 69 years of age, weighting 196.2 lb, was diagnosed with malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: ascites, fatigue, gamma-glutamyltransferase increased, hepatorenal syndrome, thrombocytopenia. Sorafenib dosage: unknown. Patient was hospitalized. Patient died on 06/21/2008.

Sorafenib Side Effects Report #5795839-4
Sorafenib side effect was reported by a Physician from GERMANY on June 23, 2008. Male patient, 69 years of age, weighting 196.2 lb, was diagnosed with malignant melanoma and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: ascites, fatigue, gamma-glutamyltransferase increased, hepatorenal syndrome, thrombocytopenia. Sorafenib dosage: unknown. Patient was hospitalized. Patient died on 06/21/2008.

Sorafenib Side Effects Report #5136094-8
Sorafenib side effect was reported by a Physician from FRANCE on Mar 03, 2006. Male patient, 55 years of age, weighting 143.3 lb, was diagnosed with malignant melanoma, metastatic malignant melanoma, hypertension, pyrexia, unevaluable event and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: anorexia, epistaxis, thrombocytopenia. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with DACARBAZINE, TEMERIT, EFFERALGAN, FLAMAZINE. Patient was hospitalized. Patient recovered.

Sorafenib Side Effects Report #5150267-X
Sorafenib side effect was reported by a Physician from FRANCE on Mar 03, 2006. Male patient, 55 years of age, weighting 143.3 lb, was diagnosed with malignant melanoma, metastatic malignant melanoma, hypertension, pyrexia, unevaluable event and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: anaemia, anorexia, asthenia, disease progression, epistaxis, neutropenia, thrombocytopenia. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with DACARBAZINE, TEMERIT, EFFERALGAN, FLAMAZINE. Patient was hospitalized. Patient recovered.


Sorafenib Side Effects Report #5949742-7
Sorafenib side effect was reported by a Physician from SPAIN on Nov 07, 2008. Male patient, 66 years of age, weighting 172.0 lb, was diagnosed with lung neoplasm malignant, haemoptysis, prophylaxis against gastrointestinal ulcer and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: febrile neutropenia, gastric perforation, oesophageal haemorrhage, peripheral ischaemia, pneumonia What is  pneumonia, thrombocytopenia, tumour associated fever. Sorafenib dosage: unknown. During the same period patient was treated with GEMCITABINE, CISPLATIN, CODEISAN, RANITIDINA. Patient was hospitalized. Patient died on 10/25/2008.

Sorafenib Side Effects Report #5311142-0
Sorafenib side effect was reported by a Physician from GERMANY on Apr 23, 2007. Male patient, 71 years of age, weighting 154.3 lb, was diagnosed with hepatic neoplasm malignant and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: haemoptysis, haemorrhage subcutaneous, thrombocytopenia. Sorafenib dosage: unknown. During the same period patient was treated with METOPROLOL SUCCINATE, DIBLOCIN, PANTOZOL, NORVASC, ZOCOR. Patient was hospitalized. Patient recovered.

Sorafenib Side Effects Report #5449967-3
Sorafenib side effect was reported by a Physician from JAPAN on Sept 05, 2007. Male patient, 70 years of age, weighting 123.5 lb, was diagnosed with hepatic neoplasm malignant, chronic hepatitis and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, thrombocytopenia. Sorafenib dosage: UNIT DOSE: 200 MG. During the same period patient was treated with URSO. Patient was hospitalized. Patient recovered.

Sorafenib Side Effects Report #5486601-0
Sorafenib side effect was reported by a Physician from JAPAN on Oct 11, 2007. Male patient, 70 years of age, weighting 123.5 lb, was diagnosed with hepatic neoplasm malignant, chronic hepatitis and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: thrombocytopenia. Sorafenib dosage: UNIT DOSE: 200 MG. During the same period patient was treated with URSO. Patient was hospitalized. Patient recovered.

Sorafenib Side Effects Report #6020351-7
Sorafenib side effect was reported by a Pharmacist from UNITED STATES on Dec 23, 2008. Male patient, 62 years of age, was diagnosed with hepatic neoplasm malignant, upper respiratory tract infection, urinary tract infection What is  urinary tract infection and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: thrombocytopenia. Sorafenib dosage: 200 MG BID PO. During the same period patient was treated with PIPERACILLIN AND TAZOBACTAM, PIPERACILLIN AND TAZOBACTAM. Patient was hospitalized. Patient recovered.


Sorafenib Side Effects Report #5627662-5
Sorafenib side effect was reported by a Pharmacist from UNITED STATES on Feb 14, 2008. Male patient, 57 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: condition aggravated, diarrhoea, pyrexia, thrombocytopenia. Sorafenib dosage: 200 MG TWICE DAILY PO. During the same period patient was treated with INDERAL, LASIX. Patient was hospitalized. Patient recovered.

Sorafenib Side Effects Report #5771802-4
Sorafenib side effect was reported by a Health Professional from UNITED STATES on June 12, 2008. Male patient, 57 years of age, weighting 156.0 lb, was diagnosed with hepatic neoplasm malignant and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: asthenia, febrile neutropenia, malaise, mouth ulceration, thrombocytopenia. Sorafenib dosage: 400 MG BID PO. Patient was hospitalized. Patient recovered.

Sorafenib Side Effects Report #5491640-X
Sorafenib side effect was reported by a Physician from ITALY on Oct 17, 2007. Male patient, 36 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: thrombocytopenia. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with LANSOPRAZOLE, KETOROLAC, PREDNISONE, METOCLOPRAMIDE, SERTRALINE. Patient was hospitalized. Patient died on 10/14/2007.

Sorafenib Side Effects Report #5623344-4
Sorafenib side effect was reported by a Physician from ITALY on Feb 11, 2008. Male patient, 36 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Sorafenib. After drug was administered, patient experienced the following side effects: thrombocytopenia. Sorafenib dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with LANSOPRAZOLE, KETOROLAC TROMETHAMINE, PREDNISONE, METOCLOPRAMIDE, SERTRALINE. Patient was hospitalized. Patient died on 10/14/2007.

Sorafenib Side Effects Report #5628623-2
Sorafenib side effect was reported by a Pharmacist from UNITED STATES on Feb 14, 2008. Male patient, 53 years of age, was treated with Sorafenib. After drug was administered, patient experienced the following side effects: thrombocytopenia. Sorafenib dosage: 400MG BID PO. Patient recovered.

Sorafenib Side Effects Report #5702901-0
Sorafenib side effect was reported by a Pharmacist from UNITED STATES on Apr 10, 2008. Male patient, 53 years of age, was treated with Sorafenib. After drug was administered, patient experienced the following side effects: thrombocytopenia. Sorafenib dosage: 400MG BID PO. Patient recovered.

Sorafenib Side Effects Report #5942194-2
Sorafenib side effect was reported by a Pharmacist from UNITED STATES on Nov 04, 2008. Male patient, 53 years of age, was treated with Sorafenib. After drug was administered, patient experienced the following side effects: thrombocytopenia. Sorafenib dosage: 400 MG BID PO. Patient recovered.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Sorafenib